Arrowhead Pharmaceuticals · 5 hours ago
Specialist, Accounts Payable
Arrowhead Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing innovative drugs for genetic diseases. They are seeking an Accounts Payable Specialist to assist in processing disbursements and implementing new systems within the Accounting Team.
BiotechnologyHealth CareNanotechnologyPharmaceutical
Responsibilities
Verify and process invoices
Research and address invoice related issues with Purchasing team, requestors, vendors, and others
Create Check, ACH and Wire payment files
File AP documents
Assist in system implementations
Assist in processing Concur expense reports for Travel & Expense reimbursements
Assist in the year-end preparation of 1099s
Prepare Accounts payable reports as needed
Ad hoc AP-related projects
Qualification
Required
Business Degree or at least 2 years of relevant experience
Ability to gather, analyze and interpret information for completeness and accuracy; excellent attention to detail; and, excellent organizational skills
Proficient in Microsoft Office suite
Strong communication skills (oral & written); ability to effectively interact with others at all levels – within and outside of finance
Flexibility to put in extra hours during critical times such as month, quarter, and year-end close cycles
Strong time management with the ability to work independently and in a group setting
Preferred
Experience with an automated workflow ERP System, Microsoft D365 is a plus
Experience with Concur expense reporting
Benefits
Competitive salaries
Excellent benefit package
Company
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin.
Funding
Current Stage
Public CompanyTotal Funding
$2.45BKey Investors
Sarepta TherapeuticsSixth StreetSilence Therapeutics
2026-01-07Post Ipo Equity· $200M
2026-01-07Post Ipo Debt· $625M
2024-11-26Post Ipo Equity· $325M
Leadership Team
Christopher Anzalone
President and Chief Executive Officer
Recent News
2026-01-14
Company data provided by crunchbase